Center for Health and Aging (CHA)

History

Founded in 2004 to examine the 21st century’s unprecedented demographic and epidemiological transitions, the Center for Health and Aging tackles a wide variety of projects and initiatives, including founding and organizing the Pacific Health Summit between 2005 and 2012.

In addition to the Summit, CHA has also organized major cross-sector meetings in Beijing, Tokyo, Singapore, Mumbai, London, and Washington, D.C., and has served a unique role in bringing together leaders from science, industry, medicine, public health, and government to focus on the world’s most important health challenges. Core themes have included vaccines, pandemics, demographic shifts, health technology, nutrition, and infectious disease.

In conjunction with its role as a "trusted convener," CHA has developed a library of policy case studies, expert interviews, reports, and white papers that inform crucial discussions among the world’s leaders in both the public and private sectors.

The mission of the Center for Health and Aging (CHA) is to facilitate constructive dialogue between science, industry, and policy and conduct research that highlights unique opportunities to improve health through creative policy and cross-sector collaboration.

Our current focus includes research on the life sciences sector in Asia—particularly in China and Japan—and its impact on health innovation and international relations.

CHA’s current research focuses on new government investments in life sciences in Asia and their impact on innovation and international relations. Key projects include “The Globalization of China’s Life Science Sector” and “Leveraging New Investments in Japan’s Life Science Sector for Renewed Economic Growth." Learn more.

CHA’s Impact & Innovation Series inspires thoughtful policy action through highlighting the personal experience and motivation of transformational health leaders. The series features visionary thought pieces on the key issues, challenges, and opportunities for which creative innovation is essential to impact. Learn more.

The Pacific Health Summit brought together high-level leaders in science, industry, and policy to form new partnerships, ideas, and relationships toward the goal of a healthier world between 2005 and 2012. Over the course of eight years, the Summit tackled critical issues in global health: early prevention and detection of disease, pandemic flu, malnutrition, multi-drug resistant tuberculosis, maternal and newborn health (MNH), vaccines, and affordability and technologies in health. Learn more.

Contact

For more information about the Center for Health and Aging (CHA), please contact:

Tachi Yamada Joins NBR Board of Directors

As a member of NBR's Board of Directors since April 2013, Dr. Yamada provides guidance on NBR’s research agenda, particularlyour work on global health. Dr. Yamada serves as Executive Vice President, Chief Medical and Scientific Officer, and Board Member for Takeda Pharmaceuticals. Prior to assuming this role, he was President of Global Health for the Bill & Melinda Gates Foundation and served on the Executive Committee for the Pacific Health Summit.
Read Dr. Yamada's full bio.

On April 3, Benjamin Shobert, NBR Senior Associate for International Health, testified before the U.S.-China Economic and Security Review Commission at the hearing on "China's Healthcare Sector, Drug Safety, and the U.S.-China Trade in Medical Products."